ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Buvidal 16 mg, Depot-Injektionslösung - 
67941009 Future Health Pharma GmbH
Buvidal 16 mg, Depot-Injektionslösung17.12.2020
  17.12.2020
Buprenorphine (N07BC01) 
WHO-DDD 
01.01.30. 
01.01.30. 
A+  
Yes 
IP 
54.96Yes
    
10 %76.20
  
7680679410091Synthetika
  
Composition
buprenorphinum 16 mg, ethanolum anhydricum 30.62 mg, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.32 ml.
Packungsbestandteile
Depot-Injektionslösung 
  
 
Active AgentDose
Buprenorphinum16mg / 0.32ml
BAG: Active AgentDose
Buprenorphinum16 mg
 
Inactive agentsDose
Ethanolum Anhydricum30.62mg / 0.32ml
Glyceroli Dioleas 
Phosphatidylcholinum ex Soja 
 
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home